Seeding and scaling Ontario’s premiere entrepreneurial ventures for patients and the economy.
Our investments have resulted in significant partnerships, clinical trials, job creation and leveraged financing for the province.
June 24, 2026 – FACIT’s new Investment and Asset Management Committee to provide strategic and expert advice on investment opportunities and advise on the growth and performance of FACIT’s portfolio.
April 24, 2026 – The $100,000 Ernsting Entrepreneurship award at FACIT’s Falcons’ Fortunes pitch competition was awarded to Mann Parikh, Founder and CEO of NerView Surgical.
March 5, 2026 – As International Women’s Day approaches on March 8, 2026, FACIT is pleased to celebrate the achievements of women-led health and biotech companies that are driving innovative cancer solutions to help patients lead longer and healthier lives.
See more news stories or subscribe to receive updates from FACIT.
We were established by the Ontario Institute for Cancer Research (OICR) to support commercialization, technology transfer, and development activities. OICR conducts and enables world-class cancer research, filling a critical role as a pan-provincial connector of oncology researchers, resources and cancer innovation development. Together with OICR, we drive a shared vision to attract more R&D investment in Ontario and help the best oncology innovations reach the market and save lives.
FACIT is funded in part by the Government of Ontario through OICR